The Pathogenesis of the Diabetic Kidney and the Role of Insulin-Like Growth Factor

United States Renal Data System's 1990 Annual Data Report. III. Causes of ESRD. Am J Kidney Dis 1990; 16: Suppl 2: 22–7.

Reichard P. , Rosenquist U. . Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and nephropathy. J Intern Med 1989; 226: 81–7.

Mogensen C.E. , Chachati A. , Christensen C.K. . Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985-6; 9: 85–95.

Hallab M. , Bled F. , Ebran J.M. . Elevated serum angiotensin converting enzyme activity in type I, insulin-dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 1992; 29: 82–5.

Marre M. , Bernadet P. , Gallois Y. . Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384–8.

Mangili R. , Bending J.J. , Scott G. . Increased sodiumlithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988; 318: 146–50.

Dudley C.R.K. , Keavney B. , Stratton I.M. , Turner R.C. , Ratcliffe P.J. . U.K. Prospective Diabetes Study XV: Relationship of reninangiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48: 1907–11.

Mathiesen E.R. , Hommel E. , Giese J. . Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991; 303: 81–7.

Marre M. , Chatelher G. , Leblanc H. . Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988; 297: 1092–5.

Ravid M. , Savin H. , Jutrin I. . Long term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577–81, 1993.

Christiansen J.S. , Gammelgaard J. , Frandsen M. , Parving H-H Increased kidney size, glomerular filtration rate and renal plasma flow in short term insulin-dependent diabetics. Diabetologia 1981; 20: 451–6.

Christiansen J.S. , Gammelgaard J. , Tronier B. . Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 1982; 21: 683–8.

Hostetter T.H. , Troy J.L. , Brenner B.M. . Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19: 410–5.

Jensen P.K. , Christiansen J.S. , Steven K. , Parving H-H Renal function in streptozotocin-diabetic rats. Diabetologia 1981; 21: 409–14.

Zatz R. , Meyer T.W. , Rennke H.G. , Brenner B.M. . Predominance of hemodynamic rather than metobolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985; 82: 5963–7.

Zatz R. , Brenner B.M. . Diabetic microangiopathy, the hemodynamic view. Am J Med 1986, 80: 443–53.

Nakamoto Y. , Takazakura E. , Hayakawa H. . Intrarenal microaneurysms in diabetic nephropathy. Lab Invest 1980; 42: 433–9.

Colwell J. , Haluska P.V. , Sarji K. , Levine J. , Sagel J. , Nair R.M. . Altered platelet function in diabetes mellitus. Diabetes 1976; 25(suppl.) 2: S8f26–831.

Zatz R. , Dunn B.R. , Meyer T.W. , Andersen S. , Rennke H.G. , Brenner B.M. . Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925–30.

Nakamoto Y. , Dohi K. , Fujike H. , Yuri T. , Shinoda A. , Takeuchi J. . Microangiographic evaluation of the effects of heparin on progressive Masugi nephritis. Kidney Int 1978; 13: 297–305.

DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 1993; 329: 977–86.

Zatz R. , Meyer T.W. , Rennke H.G. , Brenner B.M. . Predominance of hemodynamic rather than metobolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985; 82: 5963–7.

Remuzzi A. , Perico N. , Amuchastegui C.S. . Short and long term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993; 4: 40–49.

Skidgel R.A. , Schulz W.W. , Tam L.T. , Erdos E.G. . Human renal angiotensin I converting enzyme and neutral endopeptidase. Kidney Int 1987; 20: S45–S46.

Hutchinson F.N. , Martin V.I. . Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome. Am J Physiol 1990; 258: F1237–44.

Parving H-H , Andersen A.R. , Smidt U.M. , Christiansen J.S. , Oxenboll B. , Svendsen P.A. . Diabetic nephropathy and arterial hypertension: the effect of antihypertensive treatment. Diabetes 1983; 32(suppl.) 2: S83–7.

Parving H-H , Andersen A.R. , Hommel E. , Smidt U. . Effects of long term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension 1985; 7: (suppl II): S114–7.

Morgensen C.E. , Christensen C.K. . Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.

Lewis E.J. , Hunsicker L.G. , Bain R.P. . The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–62.

Timpl R. . Structure and biological activity of basement membrane proteins. Eur J Biochem 1989; 180: 487–502.

Cohen M.P. , Klepser H. , Wu V-Y Under sulfation of the glomerular basement membrane heparin sulfate in experimental diabetes and lack of correction with aldose reductase inhibition. Diabetes 1988; 37: 1324–7.

Seyer-Hansen K. . Renal hypertrophy in experimental diabetes. Kidney Int 1983; 23: 643–6.

Cortes P. , Lewin N.W. , Dumler F. , Rubinstein A.H. , Verghese C.P. , Venkatachalam K.K. . Uridine triphosphate and RNA synthesis during diabetes-induced kidney growth. Am J Physiol 1980; 238: E349–57.

Rasch R. , Rytter-NRrgaard J.O. . Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 1983; 25: 280–7.

Blundell T.L. , Bedarkar L.S. , Humbel R.E. . Tertiary structures, receptor binding, and antigenicity of insulin-like growth factors. Fed Proc 1983; 42: 2592–7.

Salmon W.D. , Daughaday W.H. . A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957; 49: 825–36.

Roberts C.T. Jr. , Lasky S.R. , Lowe W.L. Jr. , Seaman W.T. , LeRoith D. . Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1987; 1: 243–48.

Rechler M.M. , Nissley S.P. . The nature and regulation of the receptor for insulin-like growth factors. Annu Rev Physiol 1985; 47: 425–42.

Yarden Y. , Ullrich A. . Growth factor receptor tyrosine kinases. Annu Rev Biochem. 1988; 57: 443–78.

Ullrich A. , Gray A. , Tam W. . Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986; 5: 2503–2512.

Rechler M.M. , Nissley S.P. . Insulin-like growth factors. In: Sporn M.B. , Roberts A.B. , eds. Peptide growth factors and their receptors. First ed. Volume 95 of Handbook of experimental pharmacology. New York: Springer-Verlag, 1990; 263–367.

Conti F.G. , Striker L.J. , Lesniak M.A. , Mackay A. , Roth J. , Striker G.E. . Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology 1988; 122: 2788–95.

Bortz J.D. , Rotwein P. , Devol D. , Bechtel P.J. , Hansen V.A. , Hammerman M.R. . Focal expression of insulin-like growth factor I in rat kidney collecting duct. J Cell Biol 1988; 107: 811–19.

Rabkin R. , Brody M. , Lu L.H. , Chan C. , Shaheen A.M. , Gillett N. . Expression of genes according to the rat renal insulin-like growth factor-l system. J Am Soc Nephrol 1995; 6: 1511–8.

Bhaumick B. , Bala R.M. . Binding and degradation of insulin-like growth factors I and II by rat kidney membrane. Endocrinology 1987; 120: 1439–48.

Pillon D.J. , Haskell J.F. , Meezan E. . Distinct receptors for insulin-like growth factor I in rat renal glomeruli and tubules. Am J Physiol 1988; 255: E504–8.

Arnqvist H.J. , Ballermann B.J. , King G.L. . Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells. Am J Physiol 1988; 254: C411–16.

Aron D.C. , Rosenzweig J.L. , Abboud H.E. . Synthesis and binding of insulin-like growth factor I by human glomerulas mesangial cells. J Clin Endocrinol Metab 1989; 68: 585–91.

Conti F.G. , Elliot S.J. , Striker L.J. , Striker G.E. . Binding of insulinlike growth factor I by glomerular endothelial and epithelial cells: further evidence for IGF-I action in the renal glomerulus. Biochem Biophys Res Commun 1989; 163: 952–58.

Doi T. , Striker L.J. , Elliot S.J. , Conti F.G. , Striker G.E. . Insulin-like growth factor I is a progression factor for human mesangial cells. Am J Pathol 1989; 134: 395–404.

Treadway J.L. , Morrison B.D. , Soos M.A. , Siddle K. , Olefsky J. , Ullrich A. . Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci USA 1991; 88: 214–7.

Czech M.P. . Signal transmission by the insulin-like growth factors. Cell 1989; 59: 235–8.

Shenoliker S. , Nairn A.C. . Protein phosphatases: recent progress. In: Greengard P. , Robinson G.A. , eds. Advances in second messenger and phosphoprotein research. Volume 23. New York: Raven Press, 1991; 1–121.

Doi T. , Striker L.J. , Elliot S.J. , Conti F.G. , Striker G.E. . Insulin-like growth factor I is a progression factor for human mesangial cells. Am J Pathol 1989; 134: 395–404.

Guler H.P. , Zapf J. , Scheiwiller E. , Froesch E.R. . Recombinant human insulin-like growth factor stimulates growth and has direct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988; 85: 4889–93.

Hirschberg R. , Kopple J.D. . Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 1989; 83: 326–30.

Levine L. , Xiao D. , Fujiki H. . Combinations of polytoxin or 12-o-tetradecanoylphorbol-13-acetate and recombinant human insulin growth factor-1 or insulin synergistically stimulate prostaglandin production in cultured rat liver cells and squirrel monkey aorta smooth muscle cells. Prostaglandins 1986; 31: 669–81.

Baxter R.C. , Martin J.L. . Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989; 1: 49–68.

Werner H. , Shen-Orr Z. , Stannard B. , Burguera B. , Roberts C.T. Jr. LeRoith D. Experimental diabetes increases insulin-like growth factor I and II receptor concentration and gene expression in kidney. Diabetes 1990; 39: 1490–7.

Ikari N. , Yoshino H. , Moses A.C. , Flier J.S. : Evidence that receptor aggregation may play a role in transmembrane signaling through the insulin-like growth factor receptor. Mol Endocrinol 1988; 2: 831–7.

Flyvbjerg A. , Thorlacius U.O. , Naeraa R. , Ingerstev J. , Orskov H. . Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomised rats. Diabetologia 1988; 31: 310–4.

Lajara R. , Rotwein P. , Bortz J.D. . Dual regulation of insulin-like growth factor I expression during renal hypertrophy. Am J Physiol 1989; 257: F252–61.

Guler H.P. , Zapf J. , Scheiwiller E. , Froesch E.R. . Recombinant human insulin-like growth factor stimulates growth and has direct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988; 85: 4889–93.

Skottner A. , Clark R.G. , Fryklund L. , Robinson ICAF Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology 1989; 124: 2519–26.

Matthews L.S. , Hammer R.E. , Behringer R.R. . Growth enhancement of transgenic mice expressing human insulinlike growth factor I. Endocrinology 1988; 123: 2827–33.

Guler H.P. , Schmid C. , Zapf J. , Froesch E.R. . Effects of recombinant insulin-like growth factor on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 1989; 86: 2868–72.

Feld S.M. , Hirschberg R. , Artishevsky A. . Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int 1995; 48: 45–51.

Flyvbjerg A. , Bornfeldt K.E. , Marshall S.M. , Arnqvist H.J. , Orskov H. . Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 1990; 33: 334–8.

Flyvjberg A. , Frystyk J. , Thorlacius-Ussing O. , Orskov H. . Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 1989; 32: 261–5.

Flyvbjerg A. , Orskov H. . Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: Relation to severity of diabetes. Acta Endocrinol (Copenh) 1990; 122: 374–8.

Flyvbjerg A. , Frystyk J. , Marshall S.M. . Additive increase in kidney insulin-like growth factor I and initial renal enlargement in uninephrectomized-diabetic rats. Horm Metab Res 1990; 22: 516–20.

Guler H.P. , Eckardt K.U. , Zapf J. , Bauer C. , Froesch E.R. . Insulinlike growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol 1989; 121: 101–6.

Brismar K. , Gutniak M. , Povoa G. , Werner S. , Hall K. . Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 1988; 11: 599–602.

Suikkari A-M , Loivisto V.A. , Koistinen R. , Seppala M. . Dose-response characteristics for suppression of low molecular plasma insulin-like growth factor binding protein by insulin. J Clin Endocrinol Metab 1989; 68: 135–40.

Ooi G.T. , Orlowski C.C. , Brown A.L. , Becker R.E. , Unterman T.G. , Rechler M.M. . Different tissue distribution and hormonal regulation of mRNAs encoding rat insulin-like growth factor binding proteins rlGFBP-1 and rlGFBP-2. Mol Endocrinol 1990; 4: 321–8.

Bar R.S. , Boes M. , Clemmons D.R. , Busby W.H. , Sandra A. , Dake B.L. . Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology 1990; 127: 497–9.

Merimee T.J. . A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. N Engl J Med 1978; 298: 1217–22.

Falkheden T. , Wickbom J. . Renal function and kidney size following hypophysectomy in man. Acta Endocrinol 1965; 48: 348–54.

Hirschberg R. , Kopple J.D. . Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I. Am J Nephrol 1988; 8: 249–53.

Kobayashi S. , Nogami H. , Ikeda T. . Growth hormone and nutrition interact to regulate expressions of kidney IGF-I and IGFBP mRNAs. Kidney Int 1995; 48: 65–71.